Drug Trial Radar · NCT07160335
A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
174
Planned (sponsor's estimate)
Start
Sep 26, 2025
Primary completion
Apr 30, 2027
Study completion Mar 27, 2028
Sponsor
- Lead sponsor
- Shanghai Henlius BiotechIndustry
- Sponsor type
- Industry
- First posted
- Sep 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, parallel-controlled phase I clinical study to evaluate the similarity in PK profile, efficacy, safety, and immunogenicity of HLX17 vs. US-sourced Keytruda® in patients with resected non-small cell lung cancer (NSCLC) or melanoma (MEL), or renal cell carcinoma (RCC).
Conditions
- Non-small Cell Lung Cancer
- Melanoma
- Renal Cell Carcinoma
Interventions
HLX17Drug
Subjects will receive HLX17 (200 mg) on Day 1 of each 3-week cycle
US-sourced Keytruda®Drug
Subjects will receive US-sourced Keytruda® (200 mg) on Day 1 of each 3-week cycle
Primary outcomes
What the sponsor says the trial is designed to measure.
- AUC0-21dTime frame: rom time 0 to 21 days after the 1st dose (3 weeks)
- AUCssTime frame: from time 0 to 21 days after the 6th dose (18 weeks)
Locations
69 sites in 4 countries. Site status is shown where the registry gives one.
Oncology Physicians Network (OPN) - Glendale
Glendale, California
Oncology Physicians Network (OPN)- Los Alamitos
Los Alamitos, California
HCA
Los Angeles, California
Los Angeles Cancer Network
Los Angeles, California
Oncology Physicians Network (OPN) - San Bernardino
San Bernardino, California
BRCR Global
Deerfield Beach, Florida
D&H National Research Center
Margate, Florida
Ocala Oncology
Ocala, Florida
Mid Florida Hematology and oncology Center
Orange City, Florida
Oncology Consulatants (P1 Trials -Exigent Network)
Houston, Texas
American Oncology Network Vista Oncology Division
Olympia, Washington
Northwest Medical Specialties PPLC (P1 Trials - Exigent Network )
Tacoma, Washington
The First Affiliated Hospital of Bengbu Medical College
Bengbu, China
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
The First Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China
Beijing Chest Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Hunan Provincial Cancer Hospital
Hunan, Changsha, China
Fujian Cancer Hospital
Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
The Second Hospital of Lanzhou University
Lanzhou, Gansu, China
Cangzhou Central Hospital
Cangzhou, Hebei, China
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Hubei Cancer Hospital
Wuhan, Hubei, China
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The First Hospital of Jilin University
Changchun, Jilin, China
Liaoning Cancer Hospital and Institute
Shenyang, Liaoning, China
Liaoning Cancer Hospital and Institute
Shenyang, Liaoning, China
Guangxi Medical University Cancer Center
Guangxi, Nanning, China
Binzhou Medical University Hospital
Binzhou, Shandong, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Cancer Hospital of Shandong First Medical University
Jinan, Shandong, China
Linyi Cancer Hospital
Linyi, Shandong, China
Showing 40 of 69 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.